September 30, 2018

Seafood allergy: A comprehensive review of fish and shellfish allergens

Molecular Immunology

Volume 100, August 2018, Pages 28-57

https://doi.org/10.1016/j.molimm.2018.04.008

Highlights

•: Immunological cross-reactivity between fish and shellfish allergens has not been demonstrated conclusively.

A comparative analysis of errors in inhaler technique among COPD versus asthma patients

International Journal of Chronic Obstructive Pulmonary Disease Volume 2018:13 Pages 2941—2947

Birsen Ocakli,¹Ipek Ozmen,¹Eylem Acartürk Tunçay,¹Sinem Gungor,¹ Hilal Altinoz,¹ Nalan Adiguzel,¹Zafer Ali Sak,² Gokay Gungor,¹Zuhal Karakurt,¹ Peri Arbak³

¹University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey; ²Department of Chest Diseases, Harran University, Faculty of Medicine, Sanliurfa, Turkey; ³Department of Chest Diseases, Duzce University, Faculty of Medicine, Duzce, Turkey

Purpose: This study was designed to evaluate errors in inhaler technique in COPD vs asthma patients and to investigate the association of poor inhaler technique with patient demographics and clinical variables.

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France

Research
Open Access

Patrick BlinEmail author View ORCID ID profile,

Pascal Demoly,

Martine Drouet,

Bruno Falissard,

Séverine Lignot-Maleyran,

Hélène Maizi,

Simon Lorrain,

Régis Lassalle,

Cécile Droz-Perroteau,

Nicholas Moore and

Mathieu Molimard

Allergy, Asthma & Clinical Immunology201814:38

Abstract

Background

Allergic rhinitis affects around one quarter of the Western European population. Prophylactic allergen immunotherapy may be useful to reduce the risk of acute symptomatic attacks (hayfever). A five-grass pollen extract sublingual immunotherapy (5GPE-SLIT) has been developed for the treatment of allergic rhinitis to grass pollen.

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis

Current Treatment Options in Allergy

September 2018, Volume 5, Issue 3, pp 275–290

Martin Penagos

Aarif O. Eifan

Stephen R. Durham

Guy W. Scadding

Open Access

Specific Immunotherapy (L Cox, Section Editor)

First Online: 31 August 2018

Part of the following topical collections:

Topical Collection on Specific Immunotherapy

Abstract

Rationale

Subcutaneous and sublingual immunotherapy are effective for allergic rhinitis. An important question is whether allergen immunotherapy provides a sustained clinical effect after treatment cessation. In view of potential side effects, cost and the necessary patient commitment, long-term benefit is an important consideration for the recommendation of immunotherapy over standard pharmacotherapy.

The following new articles have just been published in Allergy, Asthma & Clinical Immunology

Allergy, Asthma & Clinical Immunology

The following new articles have just been published in Allergy, Asthma & Clinical Immunology

REVIEW

Anaphylaxis

David Fischer, Timothy K. Vander Leek, Anne K. Ellis and Harold Kim

Allergy, Asthma & Clinical Immunology 2018, 14:54 | Published on: 12 September 2018

Full Text | PDF

Common allergies in urban adolescents and their relationships with asthma control and healthcare utilization

Research Open Access

Hyekyun Rhee

,
Tanzy Love,
Donald Harrington and
Annette Grape

Allergy, Asthma & Clinical Immunology201814:33

Urban adolescents suffer a disproportionate burden of asthma morbidity, often in association with allergies. Literature is limited on comparing various types of allergies regarding prevalence and associations with asthma morbidity in urban dwelling adolescents. The purpose of this study was to examine the prevalence of common allergies reported by urban adolescents and to assess their relationships to healthcare utilization and asthma control.

Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood

Edward Mitre, MD1; Apryl Susi, MS2; Laura E. Kropp, MPH1; et alDavid J. Schwartz, MD3; Gregory H. Gorman, MD2; Cade M. Nylund, MD2

JAMA Pediatr. 2018;172(6):e180315. doi:10.1001/jamapediatrics.2018.0315

Key Points

Question Does use of medications that disturb the microbiome in infancy increase subsequent risk of developing allergic diseases?

Findings In this cohort study of 792 130 children, the hazard of developing an allergic disease was significantly increased in those who had received acid-suppressive medications or antibiotics during the first 6 months of life.